Back to Search
Start Over
Targeting the equilibrative nucleoside transporter ENT1 in Huntington disease.
- Source :
-
Oncotarget [Oncotarget] 2017 Feb 21; Vol. 8 (8), pp. 12550-12551. - Publication Year :
- 2017
- Subjects :
- Age of Onset
Animals
Animals, Genetically Modified
Biomarkers metabolism
Brain metabolism
Carrier Proteins genetics
Carrier Proteins metabolism
Dilazep pharmacology
Dipyridamole pharmacology
Disease Models, Animal
Disease Progression
Equilibrative Nucleoside Transporter 1 antagonists & inhibitors
Equilibrative Nucleoside Transporter 1 genetics
Humans
Huntingtin Protein genetics
Mice
Neurons metabolism
Rats
Receptor, Adenosine A2A metabolism
Ticagrelor pharmacology
Corpus Striatum metabolism
Equilibrative Nucleoside Transporter 1 metabolism
Huntington Disease metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1949-2553
- Volume :
- 8
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Oncotarget
- Publication Type :
- Editorial & Opinion
- Accession number :
- 28179589
- Full Text :
- https://doi.org/10.18632/oncotarget.15111